Cross-linking of CD81 by HCV-E2 protein inhibits human intrahepatic plasmacytoid dendritic cells response to CpG-ODN

Cellular Immunology

Volumn 284, Issue 1-2, 2013, Pages 98-103

  Tu, Zhengkun ^a   Zhang, Ping ^a   Li, Haijun ^a   Niu, Junqi ^a   Jin, Xia ^b   Su, Lishan ^a,c  

^a JILIN UNIVERSITY   (China)

^b INSTITUTE PASTEUR OF SHANGHAI   (China)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

CpG oligodeoxynucleotides (CpG ODN); Cross linking; Hepatitis C virus envelop protein (HCV E); Plasmacytoid dendritic cells (pDCs); Toll like receptor 9 (TLR9)

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD81 ANTIGEN; CD86 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; GLYCOPROTEIN E2; HLA DR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOLATED LIVER; LIVER GRAFT; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RECEPTOR DOWN REGULATION;

CPG OLIGODEOXYNUCLEOTIDES (CPG-ODN); CROSS-LINKING; HEPATITIS C VIRUS ENVELOP PROTEIN (HCV-E); PLASMACYTOID DENDRITIC CELLS (PDCS); TOLL-LIKE RECEPTOR 9 (TLR9);

ANTIGENS, CD81; CELL SURVIVAL; DENDRITIC CELLS; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, INNATE; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; OLIGODEOXYRIBONUCLEOTIDES; VIRAL ENVELOPE PROTEINS;

EID: 84882756430     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.07.012     Document Type: Article

References (33)

1. Dustin L.B., Rice C.M. Annu. Rev. Immunol. 2007, 25:71-99.
2. Beignon A.S., McKenna K., Skoberne M., Manches O., DaSilva I., Kavanagh D.G., Larsson M., Gorelick R.J., Lifson J.D., Bhardwaj N. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 2005, 115:3265-3275.
3. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S. Species-specific recognition of singlestranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
4. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., Lien E., Nilsen N.J., Espevik T., Golenbock D.T. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 2004, 5:190-198.
5. Shiina M., Rehermann B. Cell culture-produc ed hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology 2008, 47:385-395.
6. Gondois-Rey F., Dental C., Halfon P., Baumert T.F., Olive D., Hirsch I. Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparis on with influenza and human herpes virus type-1. PLoS One 2009, 4:e4319.
7. Wertheimer A.M., Bakke A., Rosen H.R. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 2004, 40:335-345.
8. Nattermann J., Zimmermann H., Iwan A., von Lilienfeld-Toal M., Leifeld L., Nischalke H.D., et al. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. Hepatology 2006, 44:945-954.
9. Lai W.K., Curbishley S.M., Goddard S., Alabraba E., Shaw J., Youster J., McKeating J., Adams D.H. Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function. J. Hepatol. 2007, 47:338-347.
10. Tu Z., Bozorgzadeh A., Crispe I.N., Orloff M.S. The activation state of human intrahepatic lymphocytes. Clin. Exp. Immunol. 2007, 149:186-193.
11. Tu Z., Bozorgzadeh A., Pierce R.H., Kurtis J., Crispe I.N., Orloff M.S. TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 2008, 205:233-244.
12. Tu Z., Pierce R.H., Kurtis J., Kuroki Y., Crispe I.N., Orloff M.S. Hepatitis C virus core protein subverts the anti-viral activities of human kupffer cells. Gastroenterology 2010, 138:305-314.
13. Tu Z., Hamalainen-Laanaya H.K., Crispe I.N., Orloff M.S. Synergy between TLR3 and IL-18 promotes IFN-γ dependent TRAIL expression in human liver NK cells. Cell Immunol. 2011, 271:286-291.
14. Tseng C.T., Klimpel G.R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 2002, 195:43-49.
15. Cormier E.G., Tsamis F., Kajumo F., Durso R.J., Gardner J.P., Dragic T. CD81 is an entry coreceptor for hepatitis C virus. Proc. Natl. Acad. Sci. USA 2004, 101:7270-7274.
16. Kapadia S.B., Barth H., Baumert T., McKeating J.A., Chisari F.V. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 2007, 81:374-383.
17. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., Abrignani S. Binding of hepatitis C virus to CD81. Science 1998, 282:938-941.
18. Levy S., Todd S., Maecker H. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 1998, 16:89-109.
19. Wack A., Soldaini E., Tseng C.K., Nuti S., Klimpel G.R., Abrignani S. Binding of hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur. J. Immunol. 2001, 31:166-175.
20. Grouard G., Rissoan M.C., Filgueira L., Durand I., Banchereau J., Liu Y.J. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 1997, 185:1101-1111.
21. Crotta S., Stilla A., Wack A., D'Andrea A., Nuti S., D'Oro U., Mosca M., Filliponi F., Brunetto R.M., Bonino F., Abrignani S., Valiante N.M. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 2002, 195:35-41.
22. Verthelyi D., Zeuner R.A. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 2003, 24:519-522.
23. Zhang S., Kodys K., Babcock G.J., Szabo G. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha. Hepatology 2012, 10. 10.1002/hep.25827.
24. Krug A., Towarowski A., Britsch S., Rothenfusser S., Hornung V., Bals R., Giese T., Engelmann H., Endres S., Krieg A.M., Hartmann G. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 2001, 31:3026-3037.
25. Tel J., Lambeck A.J., Cruz L.J., Tacken P.J., de Vries I.J., Figdor C.G. Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen. J. Immunol. 2010, 184:4276-4283.
26. Hartmann G., Weiner G.J., Krieg A.M. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 1999, 96:9305-9310.
27. Szabo G., Dolganiuc A. Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Immunobiology 2005, 210:237-247.
28. Anthony D.D., Yonkers N.L., Post A.B., et al. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J. Immunol. 2004, 172:4907-4916.
29. Kanto T., Inoue M., Miyatake H., et al. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 2004, 190:1919-1926.
30. Mengshol J.A., Golden-Mason L., Castelblanco N., Im K.A., Dillon S.M., Wilson C.C., Rosen H.R. Virahep-C Study Group. Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes. Gut 2009, 58:964-973.
31. Lambert A.A., Gilbert C., Richard M., Beaulieu A.D., Tremblay M.J. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood 2008, 112:1299-1307.
32. Cao W., Zhang L., Rosen D.B., Bover L., Watanabe G., Bao M., Lanier L.L., Liu Y.J. BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacy toid dendritic cells. PLoS Biol. 2007, 5:e248.
33. Meyer-Wentrup F., Benitez-Ribas D., Tacken P.J., Punt C.J., Figdor C.G., de Vries I.J., Adema G.J. Target ing DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 2008, 111:4245-4253.